Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICStandard

VIROPTIC

TRIFLURIDINE

Standard Dose
1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary

Approval overview VIROPTIC is listed in Drugs@FDA under application 018299 (NDA).

Review priority: N/A Marketing status: Prescription Active ingredient TRIFLURIDINE Form and strength SOLUTION/DROPS;OPHTHALMIC - 1% Sponsor MONARCH PHARMS Submission history Latest submission status date: 2018-03-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview VIROPTIC is listed in Drugs@FDA under application 018299 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient TRIFLURIDINE Form and strength SOLUTION/DROPS;OPHTHALMIC - 1% Sponsor MONARCH PHARMS Submission history Latest submission status date: 2018-03-19 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.